Immunologic Responses to a Live Attenuated Oral Cholera Vaccine
Latest Information Update: 17 Feb 2026
At a glance
- Drugs PXVX 0200 (Primary)
- Indications Cholera
- Focus Pharmacodynamics
Most Recent Events
- 13 Feb 2026 Status changed from active, no longer recruiting to completed.
- 17 Dec 2024 Planned End Date changed from 1 Jan 2026 to 1 Dec 2025.
- 17 Dec 2024 Status changed from recruiting to active, no longer recruiting.